Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2 (Q3988870): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr: Adding French translations) |
(Changed label, description and/or aliases in de: Adding German translations) |
||
| label / de | label / de | ||
Citrus Bioflavonoid Hesperidin als antivirales Mittel für SARS-CoV-2 | |||
Revision as of 20:02, 13 December 2021
Project Q3988870 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2 |
Project Q3988870 in Netherlands |
Statements
416,665.0 Euro
0 references
1,100,832.232 Euro
0 references
37.85 percent
0 references
11 May 2020
0 references
31 May 2022
0 references
Color & Brain BV
0 references
9750 AA
0 references
9700 AB
0 references
Identifiers
OP-2014-2023-Noord-OPSNN0315
0 references